Varian, F. et al. (2024) Pulmonary hypertension: intensification and personalization of combination Rx (PHoenix): a phase IV randomized trial for the evaluation of dose‐response and clinical efficacy of riociguat and selexipag using implanted technologies. Pulmonary Circulation, 14(1), e12337. (doi: 10.1002/pul2.12337) (PMID:38500737) (PMCID:PMC10945040)

Stubbs, H., Lua, S., Ingram, J., Jani, B. D. , Brewis, M., Church, C. and Johnson, M. (2023) Remote exercise testing in pulmonary hypertension (PHRET). Pulmonary Circulation, 13(4), e12325. (doi: 10.1002/pul2.12325) (PMID:38148951) (PMCID:PMC10749888)

Arogundade, F., Jani, B. , Church, C., Brewis, M., Johnson, M. and Stubbs, H. (2023) The MRC Dyspnoea Scale and mortality risk prediction in pulmonary arterial hypertension: a retrospective longitudinal cohort study. Pulmonary Circulation, 13(3), e12257. (doi: 10.1002/pul2.12257) (PMID:37404903) (PMCID:PMC10315452)

Stubbs, H., Brewis, M., Church, C. and Johnson, M. (2022) Towards telemedicine in pulmonary hypertension: assessing the feasibility of remote quality of life and exercise capacity assessment. Pulmonary Circulation, 12(4), e12144. (doi: 10.1002/pul2.12144) (PMID:36381292) (PMCID:PMC9647124)

Murphy, G., Jayasekera, G. , Mullin, J., Gallagher, L. and Welsh, D. J. (2022) Exploring the failing right ventricle in pulmonary hypertension by cardiac magnetic resonance: an in vivo study utilizing Macitentan. Pulmonary Circulation, 12(3), e12124. (doi: 10.1002/pul2.12124) (PMID:36092794) (PMCID:PMC9438403)

Wilson, K. S. et al. (2020) Apoptosis signal-regulating kinase 1 inhibition in in vivo and in vitro models of pulmonary hypertension. Pulmonary Circulation, 10(2), (doi: 10.1177/2045894020922810)

Denver, N., Homer, N. Z.M., Andrew, R., Harvey, K. Y., Morrell, N., Austin, E. D. and Maclean, M. R. (2020) Estrogen metabolites in a small cohort of patients with idiopathic pulmonary arterial hypertension. Pulmonary Circulation, 10(1), pp. 1-5. (doi: 10.1177/2045894020908783)

Peacock, A. J. et al. (2020) Idiopathic pulmonary arterial hypertension and co-existing lung disease: is this a new phenotype? Pulmonary Circulation, 10(1), pp. 1-8. (doi: 10.1177/2045894020914851)

MacLean, M. (M.) R. (2018) The serotonin hypothesis in pulmonary hypertension revisited: targets for novel therapies (2017 Grover Conference Series). Pulmonary Circulation, 8(2), pp. 1-9. (doi: 10.1177/2045894018759125) (PMID:29468941)

Crowe, T., Jayasekera, G. and Peacock, A. J. (2018) Non‐invasive imaging of global and regional cardiac function in pulmonary hypertension. Pulmonary Circulation, 8(1), pp. 1-20. (doi: 10.1177/2045893217742000) (PMID:29064323) (PMCID:PMC5753990)

Blyth, K. G. , Bellofiore, A., Jayasekera, G. , Foster, J. E., Steedman, T., Chesler, N. C. and Peacock, A. J. (2017) Dobutamine stress MRI in pulmonary hypertension: relationships between stress pulmonary artery relative area change, RV performance, and 10-year survival. Pulmonary Circulation, 7(2), pp. 465-475. (doi: 10.1177/2045893217704838) (PMID:28597775) (PMCID:PMC5467938)

Awad, K. S., West, J. D., de Jesus Perez, V. and MacLean, M. (2016) Novel signaling pathways in pulmonary arterial hypertension (2015 Grover Conference Series). Pulmonary Circulation, 6(3), pp. 285-294. (doi: 10.1086/688034) (PMID:27683605) (PMCID:PMC5019081)

Stevens, H. C., Deng, L., Grant, J. S., Pinel, K., Thomas, M., Morrell, N. W., MacLean, M. R. and Baker, A. (2016) Regulation and function of miR-214 in pulmonary arterial hypertension. Pulmonary Circulation, 6(1), pp. 109-117. (doi: 10.1086/685079) (PMID:27162619) (PMCID:PMC4860547)

Johansen, A. K. Z., Dean, A., Morecroft, I., Hood, K., Nilsen, M., Loughlin, L., Anagnostopoulou, A., Touyz, R. M. , White, K. and MacLean, M. R. (2016) The serotonin transporter promotes a pathological estrogen metabolic pathway in pulmonary hypertension via cytochrome P450 1B1 pulmonary circulation. Pulmonary Circulation, 6(1), pp. 82-92. (doi: 10.1086/685023) (PMID:27162617) (PMCID:PMC4860551)

Hemnes, A. R., Kiely, D. G., Cockrill, B. A., Safdar, Z., Wilson, V. J., Al Hazmi, M., Preston, I. R., MacLean, M. and Lahm, T. (2015) Statement on pregnancy in pulmonary hypertension from the Pulmonary Vascular Research Institute. Pulmonary Circulation, 5(3), pp. 435-465. (doi: 10.1086/682230)

Grant, J. S., Morecroft, I., Dempsie, Y., van Rooij, E., MacLean, M. R. and Baker, A. H. (2013) Transient but not genetic loss of miR-451 attenuates the development of pulmonary arterial hypertension. Pulmonary Circulation, 3(4), pp. 840-850. (doi: 10.1086/674751) (PMID:25006399) (PMCID:PMC4070830)

Tsang, H. et al. (2013) Role of asymmetric methylarginine and connexin 43 in the regulation of pulmonary endothelial function. Pulmonary Circulation, 3(3), pp. 675-691. (doi: 10.1086/674440) (PMID:24618552) (PMCID:PMC4070793)

Austin, E. D., Johansen, A. K., Alzoubi, A., Lahm, T., West, J., Tofovic, S. P., MacLean, M. R. and Oka, M. (2013) Gender, sex hormones and pulmonary hypertension. Pulmonary Circulation, 3(2), pp. 294-314. (doi: 10.4103/2045-8932.114756) (PMID:24015330) (PMCID:PMC3757824)

Hansmann, G., von Gise, A., MacLean, M.R. and Archer, S.L. (2013) The first Keystone Symposia Conference on pulmonary vascular disease and right ventricular dysfunction: current concepts and future therapies. Pulmonary Circulation, 3(2), pp. 275-277. (doi: 10.4103/2045-8932.114751)